Photo of Daniel M Wagner
Daniel M Wagner
CHAIRMAN AND CEO
Daniel Wagner is an eCommerce veteran and serial entrepreneur. Prior to the World Wide Web, at the age of 20, Daniel created the first online information service M.A.I.D. decades before the internet was commercialized and built the business into the global market leader, when it was sold to Thomson Reuters. Daniel’s second company (Venda) was a pioneer in enterprise eCommerce and was founded in 1998. Venda created a cloud or on demand commerce platform that went on to run major retail customers’ eCommerce sites (including Lands End, Tesco, BooHoo, TJX Companies, Nieman Marcus and many more) and was sold to Oracle in 2014 after becoming European market leader.
Chairman of the Board
Anthony Sharp
Anthony Sharp
NON-EXECUTIVE DEPUTY CHAIRMAN
Anthony is a serial entrepreneur, investor and board leader with more than 35 years’ experience, in more than 30 tech ventures around the world, from foundation to flotation. Ant has been an early-stage investor in tens of businesses, including lastminute.com, GoAmerica, and Silicon.com. He has also built and floated businesses on the LSE, NASDAQ and several secondary markets.
Photo of Sir David Wright GCMG LVO
Sir David Wright GCMG LVO
NON-EXECUTIVE DIRECTOR
Sir David is the UK’s former ambassador to both the Republic of Korea and Japan. During his distinguished career he was Vice-Chairman of Barclays, Private Secretary to HRH The Prince of Wales and the first CEO of British Trade International, subsequently UK Trade and Investment. Sir David’s unique experience is extremely helpful to Rezolve both in Asia and elsewhere.
Photo of Dr. Steve Perry
Dr. Steve Perry
NON-EXECUTIVE DIRECTOR
Steve is an experienced Executive in Retail Financial Services and Digital Payments, He was at Visa for 25 years, firstly as Head of Strategy, then Chief Financial Officer, over 15 years as Chief Commercial Officer, and more recently as Chief Digital Officer Steve retired from Visa in December 2015. An economist by training, Steve has broad experience as a Director and Chairman of UK and European Boards.
Photo of Dr. Derek Smith
Dr. Smith
NON-EXECUTIVE DIRECTOR
Derek brings a wealth of experience providing strategic advice to a variety of international companies, from start-ups to large enterprises. He began his career as an academic, with a BA and Phd in Economics from the University of Nottingham. He then spent 16 years with The Economist in various leadership roles, including President of Asia Pacific, and more recently Smith has served as a consultant, advisor and board member for a number of small and medium sized businesses.
Photo of John Wagner
John Wagner
NON-EXECUTIVE DIRECTOR
John brings significant experience to the Rezolve board, having been the managing director of several businesses, including BMW (GB) Ltd, Volvo GB, Volkswagen/Audi, Grundig (Great Britain) Ltd, and Hasselblad (US and UK). He studied law and economics at the London School of Economics and marketing at the Institute of Marketing. He is also an alumni of the British and American program in marketing management at the Harvard Business School.
Photo of Justin King CBE
Justin King CBE
SENIOR INTERNATIONAL ADVISOR
Justin is currently Vice Chairman of Terrafirma, where he acts as an adviser to the General Partner and non-executive Director of Marks and Spencer. Justin sits on the PIB of PWC and was awarded a CBE (Commander of the Order of the British Empire) in 2011. Prior to this, Justin was the CEO of Sainsbury’s between 2004 and 2014, where he led the business through a major turnaround which led to nine years of profit growth.
Photo of Christian Angermayer
Christian Angermayer
SENIOR ADVISOR
Christian is an entrepreneur and investor. He is founder of Apeiron Investment Group, his family office, and merchant banking business. He co-founded Ribopharma, which has $13bn market cap today, and he has raised over $2bn for his portfolio companies. Christian is a significant investor in European fintech companies with a special focus on cryptocurrencies and blockchain-related business models. His biotech companies Atai Life Sciences, Rejuveron and Cambrian are developing cutting edge drugs and technologies to improve health.